Workflow
Excellent Medical Technology Group Co., Ltd(920050)
icon
Search documents
今年以来新股发行募资68.28亿元,科创板占比22.86%
Core Insights - Two new stocks were issued today: Nongda Technology issued 16 million shares at a price of 25.00 yuan, raising 400 million yuan; Zhenstone Co. issued 261 million shares at a price of 11.18 yuan, raising 2.919 billion yuan [1][2] - As of January 19, a total of 7 companies have gone public this year, raising a cumulative amount of 6.828 billion yuan, with an average fundraising of 975 million yuan per company [1][2] Fundraising Overview - The fundraising amounts for the new stocks this year are as follows: - Zhenstone Co. raised the most at 2.919 billion yuan, primarily for the construction of fiberglass product production bases and composite material production bases [1] - Hengyun Chang raised 1.561 billion yuan for projects related to semiconductor and vacuum equipment core components [1] - Other notable fundraisers include C Zhixin (1.240 billion yuan), Nongda Technology (400 million yuan), and Aisheren (270 million yuan) [1] Issuance Price and Distribution - The average issuance price of new stocks this year is 26.95 yuan, with the highest price being 92.18 yuan for Hengyun Chang [2] - The geographical distribution of new stock issuances shows a concentration in Zhejiang, Shandong, and Jiangsu, with the highest fundraising amounts from Zhejiang (3.163 billion yuan), Guangdong (1.561 billion yuan), and Chongqing (1.240 billion yuan) [2]
爱舍伦将于1月21日北交所上市,发行价格为15.98元/股
Sou Hu Cai Jing· 2026-01-19 03:08
Group 1 - Aishalon (920050) will be listed on the Beijing Stock Exchange on January 21, and will simultaneously delist from the New Third Board [1] - The issuance price is set at 15.98 yuan per share, with a total of 16.9198 million shares issued, raising a total of 270 million yuan [1] Group 2 - Aishalon focuses on the medical health sector, primarily engaged in the research, production, and sales of disposable medical consumables for rehabilitation care and medical protection [3] - The company provides ODM/OEM services for internationally renowned medical device brands and has seven self-operated factories located in Jiangsu and Thailand [3] - Aishalon's products are exported to over 50 countries and regions, including Europe, America, Japan, South Korea, the Middle East, and Africa [3] Group 3 - Revenue projections for Aishalon are 574 million yuan, 575 million yuan, and 692 million yuan for the years 2022, 2023, and 2024, respectively [3] - The net profit attributable to the parent company is expected to be 62.8181 million yuan, 66.957 million yuan, and 80.7111 million yuan for the same years [3]
Excellent Medical Technology Group Co., Ltd - filings, earnings calls, financial reports, news - Reportify